Ventura M, Elvas L, Cristóvão J, Ramalheiro G, Coelho L, Maldonado M J, da Silva M, Sá e Melo A, Providência L A
Serviço de Cardiologia, Hospitais da Universidade de Coimbra.
Rev Port Cardiol. 2000 Nov;19(11):1143-54.
The authors review permanent pacing in patients with congenital atrioventricular block (CAVB) and present their experience in permanent pacing in this pathology.
In a population of 4,355 patients submitted to implantation of permanent pacing between January 1980 and January 1998, 33 (0.75%) had CAVB. The mean age of the patient population with CAVB was 16.7 years (aged from eleven days to 35 years); 33% were below 10 years of age; 16 patients were male. The majority of the patients had symptoms of brain hypoperfusion; two patients had concomitant malignant ventricular tachyarrythmias (one of these with Torsade de Pointes due to congenital long QT syndrome). Transvenous (endocardial) pacing was used in 32 patients (two with previous epicardial pacing and exit block) and epicardial pacing in one. The mode of stimulation used was VVI in three patients, DDD in eight patients, VVIR in 14 patients, DDDR in four patients and VDD in four. Smaller pulse generators were used in children of lower weight. In recent years single lead VDD systems have been preferred whenever technically possible. Vascular access was the left cephalic vein in 17 patients; the left subclavian vein in 14 patients and the right jugular vein in one patient. During a mean follow-up of 6.9 years, two patients with ventricular stimulation systems developed "Pacemaker Syndrome" and required a change of mode of stimulation. Lead fracture and posterior cutaneous necroses were observed in two other patients, who were accordingly submitted to surgical revision. It was deemed necessary, one year later, to increase the lead loop in a child with a permanent pacemaker implanted at eleven days of age. No other complications occurred with the other patients; replacement of the pulse generators was performed in an elective manner.
CAVB is a rare indication for the implantation of a permanent pacemaker. In children, in the majority of cases, endocardial stimulation is possible in spite of the obvious technical difficulties due to low weight. Sequential, more physiological, stimulation systems should be preferred. However, VVIR stimulation systems of smaller dimensions can be the first choice of mode of stimulation in smaller children, mainly due to anatomical and technical limitations.
作者回顾先天性房室传导阻滞(CAVB)患者的永久性起搏情况,并介绍他们在这种疾病中进行永久性起搏的经验。
在1980年1月至1998年1月间接受永久性起搏植入的4355例患者中,33例(0.75%)患有CAVB。CAVB患者人群的平均年龄为16.7岁(年龄从11天至35岁);33%的患者年龄在10岁以下;16例为男性。大多数患者有脑灌注不足的症状;2例患者伴有恶性室性心律失常(其中1例因先天性长QT综合征发生尖端扭转型室速)。32例患者采用经静脉(心内膜)起搏(2例曾行心外膜起搏并存在出口阻滞),1例采用心外膜起搏。使用的刺激模式为3例患者采用VVI,8例患者采用DDD,14例患者采用VVIR,4例患者采用DDDR,4例患者采用VDD。体重较轻的儿童使用较小的脉冲发生器。近年来,只要技术上可行,单导联VDD系统更受青睐。血管通路为17例患者采用左头静脉;14例患者采用左锁骨下静脉,1例患者采用右颈静脉。在平均6.9年的随访期间,2例心室刺激系统患者出现“起搏器综合征”,需要改变刺激模式。另外2例患者观察到导线断裂和后皮肤坏死,因此接受了手术修复。1年后,认为有必要增加1例11天龄植入永久性起搏器儿童的导线环。其他患者未发生其他并发症;脉冲发生器以择期方式进行更换。
CAVB是永久性起搏器植入的罕见适应证。在儿童中,尽管由于体重低存在明显技术困难,但在大多数情况下心内膜刺激是可行的。应首选序贯性、更生理性的刺激系统。然而,尺寸较小的VVIR刺激系统可能是较小儿童刺激模式的首选,主要是由于解剖和技术限制。